Skip to main content

SCHRODER INVESTMENT MANAGEMENT GROUP

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1086619 London, X0

Position in HALO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$14,446,918
+$3,297,017 QoQ
Shares Held
184,578
+7.0% QoQ
Ownership
0.163%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#99
of 667 holders
Holding Since
Sep 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SCHRODER INVESTMENT MANAGEMENT GROUP holds $692,439,062 across 60 Biotechnology names. HALO ranks #14 (2.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in HALO

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,446,918 184,578
2026-03-31 $11,149,901 172,519
2025-12-31 $9,229,453 137,139
2025-09-30 $9,942,335 135,565
2025-06-30 $12,847,638 246,975
2025-03-31 $15,474,370 242,507
2024-12-31 $4,183,518 87,503
2024-09-30 $8,376,443 146,339
2024-06-30 $763,408 14,580
2024-03-31 $6,735,753 165,579
2023-12-31 $2,298,912 62,200
2023-06-30 $647,528 17,952
2023-03-31 $20,426,303 534,860
2022-12-31 $5,850,287 102,817
2022-09-30 $1,628,928 41,197
2021-09-30 $3,320,992 81,637
2021-06-30 $29,637,199 652,658
2021-03-31 $23,209,906 556,726
2020-12-31 $4,838,914 113,297
2020-09-30 $3,754,071 142,849